Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases.

Diagnostics (Basel) · 2015 · PMC4665591 · PMID 26854151

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Even if these results were only borderline significant, they back the earlier results of the above mentioned studies and may be useful in clinical decision making, as established breast biomarkers CEA and CA 15-3 could not provide any predictive information in this setting [ 208 , 209 ].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.